Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) announces the results of
operations for the quarter ending December 31, 2012.


Business Highlights 



--  Net Income of $132 thousand compared to a loss of $68 thousand in the
    three-month period ended December 31, 2011 (profit of $103 thousand for
    the nine month period ending December 31, 2012). 
    
--  Grew bookings 7% to $1.09 million compared to $1.02 million in the
    three-month period ended December 31, 2011. 
    
--  Increased backlog to approximately $2.76 million compared to
    approximately $2.08 million in the three-month period ended December 31,
    2011. 
    
--  Revenue up 39% to $1.10 million from $787 thousand in the three-months
    ended December 31, 2011. 



"We are pleased to see the improving sales and our continued focus on
controlling costs has resulted in both a profitable quarter and year to date,"
stated Troy Griffiths, President and CEO of Vigil Health Solutions Inc.


Financial Results

Revenue for the three-months ended December 31, 2012 was $1.10 million compared
to $787 thousand in the three-month period ended December 31, 2011, an increase
of 39%. Project revenue made up 66% of total revenue; the remaining revenue came
from follow on sales to existing customers. These sales include service and
maintenance billings and replacement products including wireless devices and
communication equipment.


Bookings for the quarter were $1.09 million up 7% compared to $1.02 million in
the three-month period ended December 31, 2011. 


At December 31, 2012 Vigil had a backlog of approximately $2.76 million
(including $875 thousand in deposits and progress billings, recorded as deferred
revenue on the balance sheet) a 33% increase compared to approximately $2.08
million (including $611 thousand in deposits and progress billings, recorded as
deferred revenue on the balance sheet) at December 31, 2011. At December 31,
2012, Vigil's backlog included 37 projects at varying stages of installation and
progress billing with an average project size of $75 thousand. This was an
increase over the 23 projects with an average value of $91 thousand in the three
months ended December 31, 2011. Projects can include individual buildings or
floors of multiple phase campus construction. 


The gross margin percentage for the three months ended December 31, 2012 was 50%
compared to 47% for the three months ended December 31, 2011. Gross margin was
slightly higher than management's usual expectations of margins of between 42%
and 47%. 


Expenditures for the three months ended December 31, 2012 were $424 thousand,
down 6% from $452 thousand for the period ended December 31, 2011. Expenses
while down quarter over quarter were up to more standard levels reflecting a
gradual return to regular hours as business activity increases.


Net income for the three month period ended December 31, 2012 was $132 thousand,
or $0.010 per share compared to a loss of $68 thousand, or $0.005 per share for
the previous year. The profitable quarter relates largely to the 39% increase in
revenue as well as improved margins and a reduction in operating costs. The
Company expects to see staffing levels and operating costs increase going
forward.


Detailed financial statements along with Management Discussion and Analysis have
been filed with SEDAR (www.sedar.com).


Financial information will be mailed to entitled security holders on February
22, 2013. Or, upon notice to the Company, entitled security holders may request
a copy of financials in advance.


Summary Financial Information



----------------------------------------------------------------------------
----------------------------------------------------------------------------
                                              December 31,     December 31, 
                                                      2012             2011 
                                               (unaudited)      (unaudited) 
----------------------------------------------------------------------------
Revenue                                      $   1,096,167    $     786,737 
Cost of sales                                      546,081          420,835 
----------------------------------------------------------------------------
                                                   550,086          365,902 
Expenses                                           424,482          451,894 
----------------------------------------------------------------------------
Income (loss) before the following items           125,604          (85,992)
Other income (expense):                              6,099           18,167 
----------------------------------------------------------------------------
Income / (loss) for the period               $     131,703    $     (67,825)
----------------------------------------------------------------------------
----------------------------------------------------------------------------



Non-IFRS Measure

For the three months ended December 31, 2012, we are disclosing Adjusted EBITDA,
a non-IFRS financial measure, as a supplementary indicator of operating
performance. We define Adjusted EBITDA as net income before, interest, income
taxes, amortization, stock based compensation and currency gains or losses
including derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it internally to make
strategic decisions, forecast future results and to evaluate our performance and
because we believe that our current and potential investors and analysts use the
measure to assess current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other companies
and it is not intended as a substitute for IFRS measures.


Adjusted EBITDA Reconciliation



----------------------------------------------------------------------------
----------------------------------------------------------------------------
                         Three months ended           Nine months ended     
                      December 31, December 31,   December 31, December 31, 
                              2012         2011           2012         2011 
----------------------------------------------------------------------------
Income / (loss) for                                                         
 the period          $     131,703      (67,825)       102,570     (374,676)
Add / (deduct)                                                              
  Foreign exchange          (9,970)      14,168        (16,731)      (9,902)
  Derivative                                                                
   exchange                     79      (34,337)         5,721       (5,287)
  Interest                   3,792        2,002         11,977       12,129 
  Stock based                                                               
   compensation             13,458        1,529         26,812        6,030 
  Amortization               3,814        5,245         12,043       17,759 
----------------------------------------------------------------------------
                            11,173      (11,393)        39,822       21,429 
----------------------------------------------------------------------------
Adjusted EBITDA      $     142,876      (79,218)       142,393     (353,247)
----------------------------------------------------------------------------
----------------------------------------------------------------------------



About Vigil Health Solutions Inc.

Vigil offers a proprietary technology platform combining software and hardware
to provide comprehensive solutions to the expanding seniors' housing market.
Vigil has established a growing presence in North America and an international
reputation for being on the leading edge of systems design and integration.
Vigil's objective is to offer solutions for the full continuum of care. Vigil's
product range includes the innovative wireless Vitality Care System(TM)
featuring discreet 'mini pendants', a nurse call system, mobile fall,
incontinence monitoring, resident check and the award-winning Vigil Dementia
System.


Certain statements contained in this news release that are not based on
historical facts may constitute forward-looking statements or forward-looking
information within the meaning of applicable securities laws ("forward-looking
statements"). These forward-looking statements are not promises or guarantees of
future performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown risks,
assumptions, uncertainties and other factors that could cause our actual
results, performance, achievements or developments in our business or in our
industry to differ materially from those expressed, anticipated or implied by
such forward-looking statements.


Forward-looking statements include all financial guidance, disclosure regarding
possible events, conditions, circumstances or results of operations that are
based on assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they are made. These
forward-looking statements appear in a number of different places in this
presentation and can be identified by words such as "may", "estimates",
"projects", "expects", "intends", "believes", "plans", "anticipates", or their
negatives or other comparable words. Forward-looking statements include
statements regarding the outlook for our future operations, plans and timing for
the introduction or enhancement of our services and products, statements
concerning strategies or developments, statements about future market
conditions, supply conditions, end customer demand conditions, channel inventory
and sell through, revenue, gross margin, operating expenses, profits, forecasts
of future costs and expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical fact.


The risk factors and uncertainties that may affect our actual results,
performance, achievements or developments are many and include, amongst others,
our ability to develop our sales force and generate revenue, the length of the
sales cycle, management of the Company's growth, ability to recruit and retain
staff, fluctuations in demand for current and future products, our ability to
develop, manufacture, supply and market existing and new products that meet the
needs of customers, volatility in the exchange rate, ability to secure
financing, ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others are discussed
in the Risks and Uncertainties section of our "Management Discussion and
Analysis" segment of our fiscal 2012 Annual Report. Many of these factors and
uncertainties are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by this cautionary
statement and there can be no assurance that actual results, performance,
achievements or developments anticipated by the Company will be realized. 


Forward-looking statements are based on management's current plans, estimates,
projections, beliefs and opinions and, except as required by law, the Company
does not undertake any obligation to update forward-looking statements should
the assumptions related to these plans, estimates, projections, beliefs and
opinions change.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Vigil Health Solutions Inc.
Troy Griffiths
President and CEO
(250) 383-6900
(250) 383-6999 (FAX)
information@vigil.com
www.vigil.com

Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.
Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.